部份中文芜地溴铵/维兰特罗处方资料（仅供参考）
英文名：Umeclidinium Bromide/Umeclidinium Bromide
商标名：ANORO ELLIPTA
中文名：芜地溴铵/维兰特罗
生产商：葛兰素史克
アノーロエリプタ7吸入用／ アノーロエリプタ30吸入用
药效分类
copd治疗配合制剂
批准日期：2014年9月
商標名
ANORO ELLIPTA 7doses
ANORO ELLIPTA 30doses
一般名
ウメクリジニウム臭化物
（Umeclidinium Bromide）
化学名
1-［2-（Benzyloxy）ethyl］-4-（hydroxydiphenylmethyl）-1-azoniabicyclo［2.2.2］octane bromide
分子式
C29H34BrNO2
分子量
508.49
構造式
性状
白色粉末。
一般名
ビランテロールトリフェニル酢酸塩
（Umeclidinium Bromide）
化学名
4-{（1R）-2-［（6-{2-［（2,6-Dichlorobenzyl）oxy］ethoxy}hexyl）amino］-1-hydroxyethyl}-2-（hydroxymethyl）phenol mono（2,2,2-triphenylacetate）
分子式
C24H33Cl2NO5・C20H16O2
分子量
774.77
構造式
性状
白色粉末。
处理上的注意
药剂交付时
(1)递交患者手册，指导使用方法。
(2)因为本药剂是为了防湿而包装的铝制品，所以要求在使用前打开铝包装。
药效药理
umec是一种长时间作用的选择性无跳素受体受体拮抗剂，对于所有的姆斯卡林受体子类型(m1。umec通过竞争性地阻碍乙酰胆碱到支气管平滑肌中存在的乙酰胆碱受体，来抑制支气管平滑肌收缩。在in vitro中，umec对m3受体的作用显示为缓慢的恢复，umec对momo的单次气管内输入，对乙酰胆碱诱发的支气管收缩显示长时间持续的抑制作用。
vi是长时间作用β2兴奋剂，通过激活丙氨酸酶来增加细胞内的循环分解酶1磷酸，从而松缓支气管平滑肌。vi从对马尔代夫的单次输入中，持续地抑制了由组胺诱发的支气管收缩。
适应症
长期维持治疗慢性阻塞性肺病。
用法与用量
本品为口腔吸入粉，每天用药一次，每次芜地溴铵/62.5mcg 维兰特罗/25mcg
包装
62.5μg/25μg
7吸入用×1
62.5μg/25μg
30吸入用×1
制造商(进口)
葛兰素史克
注：以上中文资料不够完整，使用者以原资料为准。
完整说明附件：http://www.info.pmda.go.jp/go/pack/2259806G1021_1_06/  .
Anoro Ellipta（Umeclidinium Bromide/Vilanterol Trifenatate）
Anoro Ellipta 7 doses（アノーロエリプタ7吸入用）
Brand name : Anoro Ellipta 7 doses
　Active ingredient: Umeclidinium Bromide
 Vilanterol Trifenatate
　Dosage form: Inhalation
　Print on wrapping:
Effects of this medicine
This medicine has a long bronchodilator effect by a beta 2 adrenergic receptor stimulating action and by a muscarinic receptor antagonist action. This will help relieve symptoms such as breathing difficulty caused by airway obstruction. It is usually used to treat Chronic Obstructive Pulmonary Disease (chronic bronchitis, pulmonary emphysema). It should not be used to relieve a sudden attack that has already begun.
Before using this medicine, be sure to tell your doctor and pharmacist
•If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have angle-closure glaucoma, difficulty in urination due to prostate hypertrophy.
•If you are pregnant or breastfeeding.
•If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule (How to take this medicine)
•Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>>
•In general, for adults, inhale one puff at a time, once a day. Strictly follow the instructions.
•Try to inhale this medicine at the same time each day.
•Read the instruction leaflet for users thoroughly before using this medicine.
•To wash away medicine in the mouth and/or throat, gargle after inhaling this medicine. (if you have difficulty gargling, rinse out your mouth.)
•If you miss a dose, inhale a dose as soon as possible. However, do not inhale this medicine more than once a day. You should never take two doses at one time.
•If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
•Do not stop taking this medicine unless your doctor instructs you to do so.
Precautions while taking this medicine
• Possible adverse reactions to this medicine
The most commonly reported adverse reactions include headache, dry mouth, cough, taste abnormality and high blood pressure. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
•palpitation, dizziness, faint [Atrial fibrillation]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
Storage conditions and other information
•Keep out of the reach of children. Store away from direct sunlight, heat and moisture.
•Discard the remainder. Do not store them.
GlaxoSmithKline K.K.External
Published: 10/2015
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.